Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group
Published inAntimicrobial agents and chemotherapy, vol. 44, no. 11, p. 3155-3157
Publication date2000
Abstract
Keywords
- Anti-HIV Agents/ therapeutic use
- Delavirdine/ therapeutic use
- Double-Blind Method
- Drug Resistance, Microbial
- Drug Therapy, Combination
- HIV Infections/ drug therapy
- HIV Reverse Transcriptase/genetics
- HIV-1/drug effects/genetics
- Humans
- Treatment Outcome
- Zidovudine/therapeutic use
Affiliation
Citation (ISO format)
JOLY, V. et al. Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group. In: Antimicrobial agents and chemotherapy, 2000, vol. 44, n° 11, p. 3155–3157.
Main files (1)
Article
![accessLevelRestricted](assets/images/access-level-restricted.png)
Identifiers
- PID : unige:7355
- PMID : 11036040
ISSN of the journal0066-4804